Women with breast cancer and BRCA1 mutations had a lower risk of mortality if they underwent oophorectomy, and the benefit was apparent beyond age 50,... More »
A detailed survival analysis questions the rationale behind use of the diabetes drug metformin to improve pancreatic cancer survival.
Several epidemi... More »
Metastatic triple-negative breast cancer appears to be the latest hard-to-treat cancer to yield to the juggernaut that is now anti-PD-L1 immunotherapy... More »
GENEVA – Circulating tumor DNA currently has one role to play in routine management of lung cancer patients: To check at the time of diagnosis for a... More »
The U.S. Preventive Services Task Force is continuing to recommend routine mammograms every 2 years for women starting at age 50, according to newly r... More »
Adult brain tumor survivors taking donepezil, a drug approved for the treatment of Alzheimer’s disease, showed significant improvements in the cogni... More »
Of all drugs to be released in 2015, the melanoma drug Opdivo (nivolumab) is expected to have the brightest future, according to a report from Thomson... More »
Pembrolizumab was superior to ipilimumab, the standard of care, as first-line therapy for advanced melanoma in the phase III KEYSTONE-006 trial.
Pemb... More »
Treatment of nine women with metastatic cervical cancer with single infusions of tumor-infiltrating lymphocytes grown out from tumor specimens collect... More »
HOUSTON – Surgical-site infections occurring in patients who underwent curative resection for localized colon cancer were associated with worse over... More »
